Patents (Patent (International))

Dextrin hydrogel for biomedical applications

  • International Patent, WO/2011/070529, 2011


The invention consists of an hydrogel formulation of oxidized dextrin reticulated with adipic acid dihydrazide, which may embody polysaccharides, proteins, nanogels, granular materials, bioactive molecules and cells for tissue regeneration and controlled drug delivery. The present invention provides an hydrogel which can be injectable, highly biocompatible and biodegradable, for tissue regenerative applications, performing simultaneously as a vehicle e.g. for nanogels, granular materials and cells, and as controlled drug delivery systems, e.g. of hydrophobic molecules and therapeutic proteins.

CEB Authors



ISI Web of Science® Citations: 0


Share Content